Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells
Paclitaxel has emerged as a front line treatment for aggressive malignancies of the breast, lung, and ovary. Successful therapy of cancer is frequently undermined by the development of paclitaxel resistance. There is a growing need to find other therapeutic targets to facilitate treatment of drug-re...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
National Academy of Sciences
2010
|
| Subjects: |